NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG OR JAPAN.
The Board of Directors of Bactiguard Holding AB (publ) (“Bactiguard”) confirms its intention to proceed with an IPO of Bactiguard on NASDAQ OMX Stockholm. Subject to necessary decisions being taken, receipt of NASDAQ OMX Stockholm approval and determination of favourable market conditions, the IPO is expected to take place in late June 2014.
“The planned IPO is an important milestone for Bactiguard and an important step in creating a long-term platform for the company’s continued development. A listing will contribute positively to the company’s growth opportunities and make Bactiguard’s efforts to prevent healthcare-associated infections better known among customers, the media and investors,” says Johan Rugfelt, CEO of Bactiguard.
The offer to acquire shares in Bactiguard will cover newly issued shares as well as existing shares. The shares will be offered to Swedish and international institutional investors and, in a retail offering, to the general public in Sweden.
Prior to the planned IPO, holders of Bactiguard’s corporate bonds will be contacted individually by Bactiguard and offered the option to offset their bonds against Bactiguard shares, contingent upon completion of the IPO.
Swedbank has been appointed Lead Manager and Sole Bookrunner and ABG Sundal Collier have been appointed Co-Lead Managers in connection with the intended IPO. Cederquist is legal advisor.
Bactiguard Holding AB (publ) is required to disclose the above information under the provisions of the Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 8:00 AM CET on 23 May 2014 .
Johan Rugfelt – CEO
+46 708 724 739
Cecilia Edström – Director of Communications
+46 722 262 328